| GERAX | VEMAX | GERAX / VEMAX | |
| Total Expense Ratio | 1.34 | 0.13 | 1,031% |
| Annual Report Gross Expense Ratio | 1.51 | 0.13 | 1,162% |
| Fund Existence | 18 years | 19 years | - |
| Gain YTD | 30.645 | 24.426 | 125% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | 250 | N/A | - |
| Net Assets | 2.68B | 141B | 2% |
| Annual Yield % from dividends | 0.77 | 2.75 | 28% |
| Returns for 1 year | 30.61 | 22.65 | 135% |
| Returns for 3 years | 61.91 | 50.90 | 122% |
| Returns for 5 years | 15.12 | 27.91 | 54% |
| Returns for 10 years | 69.28 | 88.05 | 79% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBTTX | 33.84 | N/A | N/A |
| Fidelity Advisor Biotechnology M | |||
| NMMEX | 19.46 | -0.18 | -0.92% |
| Northern Active M Emerging Market Equity | |||
| DGOCX | 27.91 | -0.38 | -1.34% |
| Davis Opportunity C | |||
| GEMPX | 14.81 | -0.22 | -1.46% |
| Goldman Sachs Emerging Mkts Eq ex. Chn P | |||
| ASERX | 127.42 | -2.83 | -2.17% |
| American Century Select R | |||